COVID 19

T- and B-Cell Immunology

Understanding immune responses to SARS-CoV-2 is critical for effective treatments and vaccines. IDM’s research includes:

• Investigating T-cell and B-cell responses to natural infection and vaccination.

• Identifying immune markers associated with long-term immunity and protection.

• Exploring immune evasion mechanisms and their impact on reinfection and disease severity.

Viral Evolution

Tracking SARS-CoV-2 mutations helps inform public health strategies. IDM’s research includes:

• Studying viral adaptations and their effects on transmissibility and immune escape.

• Analysing how mutations influence disease severity and treatment outcomes.

• Modelling viral evolution to predict future variants.

Genomic Surveillance

Monitoring SARS-CoV-2 genetic changes is essential for controlling outbreaks. Our work includes:

• Conducting real-time sequencing to track variant emergence and spread.

• Integrating genomic data with epidemiological studies to inform policy decisions.

• Collaborating with global networks to enhance surveillance and response efforts.

Vaccine & Diagnostics Development

Ensuring the availability of effective vaccines and diagnostic tools is a priority. Our efforts focus on:

• Developing next-generation vaccines with improved durability and broad protection.

• Evaluating vaccine efficacy against emerging variants.

• Innovating rapid and accurate diagnostic tests to detect SARS-CoV-2 and its variants.